IROX as second-line therapy for metastatic colorectal cancer

被引：0
|
作者：
Alberto Sobrero
机构：
[1] Ospedale San Martino,
来源：
Nature Reviews Clinical Oncology | 2009年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Haller et al. demonstrated that irinotecan plus oxaliplatin (IROX) is more efficacious than irinotecan alone after fluoropyrimidine failure in advanced colorectal cancer. IROX does not change, but enriches the treatment algorithm of advanced colorectal cancer at the second-line level.
引用
收藏
页码：248 / 250
页数：2
相关论文
共 50 条
  • [1] IROX as second-line therapy for metastatic colorectal cancer
    Sobrero, Alberto
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (05) : 248 - 250
  • [2] Second-line therapy for metastatic colorectal cancer
    Price, Timothy J.
    [J]. LANCET ONCOLOGY, 2015, 16 (05): : 476 - 477
  • [3] Second-line systemic therapy for metastatic colorectal cancer
    Mocellin, Simone
    Baretta, Zora
    Roque i Figuls, Marta
    Sola, Ivan
    Martin-Richard, Marta
    Hallum, Sara
    Cosp, Xavier Bonfill
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (01):
  • [4] Irinotecan in second-line therapy of metastatic colorectal cancer
    Jäger, E
    Jäger, D
    Orth, J
    Knuth, A
    [J]. ONKOLOGIE, 2000, 23 : S15 - S17
  • [5] First- and second-line therapy of metastatic colorectal cancer
    Terstriep, Shelby
    Grothey, Axel
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (06) : 921 - 930
  • [6] Second-line therapy in colorectal cancer
    Berlin, J
    [J]. ONCOLOGY-NEW YORK, 2000, 14 (12): : 21 - 26
  • [7] Second-line management of metastatic colorectal cancer
    Gallagher, David J.
    Kemeny, Nancy
    [J]. CLINICAL COLORECTAL CANCER, 2008, 7 (01) : 25 - 32
  • [8] Second-line therapy of metastatic bladder cancer
    Retz, M.
    Bokemeyer, C.
    [J]. ONKOLOGE, 2012, 18 (11): : 1018 - 1022
  • [9] Options for Second-Line Treatment in Metastatic Colorectal Cancer
    Lee, James J.
    Sun, Weijing
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (01) : 46 - 54
  • [10] Comparative analysis of the effectiveness of second-line bevacizumab plus chemotherapy in second-line therapy in metastatic colorectal cancer.
    Smagulova, Kaldigul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
12345